NO951631L - Nevrobeskyttende 3,4-dihydro-2(1H)-kinolon-forbindelser - Google Patents

Nevrobeskyttende 3,4-dihydro-2(1H)-kinolon-forbindelser

Info

Publication number
NO951631L
NO951631L NO951631A NO951631A NO951631L NO 951631 L NO951631 L NO 951631L NO 951631 A NO951631 A NO 951631A NO 951631 A NO951631 A NO 951631A NO 951631 L NO951631 L NO 951631L
Authority
NO
Norway
Prior art keywords
pct
fluoro atoms
compounds
neuroprotective
dihydro
Prior art date
Application number
NO951631A
Other languages
English (en)
Norwegian (no)
Other versions
NO951631D0 (no
Inventor
Bertrand Leo Chenard
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NO951631D0 publication Critical patent/NO951631D0/no
Publication of NO951631L publication Critical patent/NO951631L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO951631A 1992-10-30 1995-04-28 Nevrobeskyttende 3,4-dihydro-2(1H)-kinolon-forbindelser NO951631L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96964292A 1992-10-30 1992-10-30
PCT/US1993/006827 WO1994010166A1 (en) 1992-10-30 1993-07-23 Neuroprotective 3,4-dihydro-2(1h)-quinolone compounds

Publications (2)

Publication Number Publication Date
NO951631D0 NO951631D0 (no) 1995-04-28
NO951631L true NO951631L (no) 1995-04-28

Family

ID=25515803

Family Applications (1)

Application Number Title Priority Date Filing Date
NO951631A NO951631L (no) 1992-10-30 1995-04-28 Nevrobeskyttende 3,4-dihydro-2(1H)-kinolon-forbindelser

Country Status (25)

Country Link
US (1) US5852040A (xx)
EP (1) EP0666854B1 (xx)
JP (1) JP2695292B2 (xx)
KR (1) KR950704298A (xx)
CN (1) CN1039644C (xx)
AT (1) ATE150751T1 (xx)
AU (1) AU669206B2 (xx)
BR (1) BR9307331A (xx)
CA (1) CA2146260C (xx)
CZ (1) CZ280669B6 (xx)
DE (1) DE69309297T2 (xx)
DK (1) DK0666854T3 (xx)
ES (1) ES2099969T3 (xx)
FI (1) FI934800A (xx)
GR (1) GR3023264T3 (xx)
HU (1) HUT65472A (xx)
IL (1) IL107347A0 (xx)
MX (1) MX9306796A (xx)
MY (1) MY109684A (xx)
NO (1) NO951631L (xx)
NZ (1) NZ255074A (xx)
PL (1) PL173618B1 (xx)
TW (1) TW299231B (xx)
WO (1) WO1994010166A1 (xx)
ZA (1) ZA938091B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610736B (en) 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
US6200990B1 (en) 1998-12-21 2001-03-13 Alcon Laboratories, Inc. Neuroprotective agents having antioxidant and NMDA antagonist activity
KR20010069066A (ko) * 2000-01-12 2001-07-23 이종원 저산소 농도하에서 생존이 가능하도록 하는 동물세포의배양방법
US6713490B2 (en) 2002-04-26 2004-03-30 Pfizer, Inc. 3,4-dihydroquinolin-2(1H)-one compounds as NR2B receptor antagonists
MXPA06003748A (es) * 2003-10-08 2006-06-14 Pfizer Compuestos de lactama condensada.
TWI366565B (en) 2007-06-06 2012-06-21 Otsuka Pharma Co Ltd Quinolone compound and pharmaceutical composition
CN103664798A (zh) * 2012-09-20 2014-03-26 杨育新 一类治疗创伤性脑损伤疾病的化合物及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5733M (xx) * 1966-09-27 1968-01-22
JPS51118772A (en) * 1975-04-09 1976-10-18 Otsuka Pharmaceut Co Ltd Method for preparing carbostyryl derivatives
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
FR2546166B1 (fr) * 1983-05-19 1985-10-25 Synthelabo Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
EP0322361A3 (de) * 1987-12-23 1990-01-24 Ciba-Geigy Ag Weitere hydrierte 1-Benzooxacycloalkylpyridincarbonsäureverbindungen
FR2640266B2 (fr) * 1988-07-12 1992-07-10 Synthelabo Derives de (hydroxy-1 piperidinyl-2 alkyl) indolones-2, quinoleinones-2, benzo(b)azepinones-2 et benzimidazolones-2, leur preparation et leur application en therapeutique
US5506231A (en) * 1989-03-31 1996-04-09 The Children's Medical Center Corporation Treatment of aids dementia, myelopathy and blindness
ES2098248T3 (es) * 1989-05-17 1997-05-01 Pfizer Derivados de 2-piperidino-1-alcanoles como agentes antiisquemicos.
KR0163355B1 (ko) * 1990-05-10 1998-12-01 알렌 제이. 스피겔 신경보호성 인돌론 및 관련 유도체
EP0524846A1 (fr) * 1991-06-27 1993-01-27 Synthelabo Dérivés de 2-(pipéridin-1-y1) éthanol, leur préparation et leur application en thérapeutique
HUT70528A (en) * 1991-07-17 1995-10-30 Pfizer 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents and process for production thereof
US5498610A (en) * 1992-11-06 1996-03-12 Pfizer Inc. Neuroprotective indolone and related derivatives

Also Published As

Publication number Publication date
MY109684A (en) 1997-04-30
DE69309297D1 (de) 1997-04-30
ES2099969T3 (es) 1997-06-01
NO951631D0 (no) 1995-04-28
WO1994010166A1 (en) 1994-05-11
PL173618B1 (pl) 1998-04-30
GR3023264T3 (en) 1997-07-30
AU4778093A (en) 1994-05-24
DE69309297T2 (de) 1997-07-03
CN1095719A (zh) 1994-11-30
EP0666854B1 (en) 1997-03-26
BR9307331A (pt) 1999-05-25
CN1039644C (zh) 1998-09-02
US5852040A (en) 1998-12-22
PL308667A1 (en) 1995-08-21
ATE150751T1 (de) 1997-04-15
HU9303082D0 (en) 1994-01-28
KR950704298A (ko) 1995-11-17
NZ255074A (en) 1996-10-28
FI934800A0 (fi) 1993-10-29
JP2695292B2 (ja) 1997-12-24
EP0666854A1 (en) 1995-08-16
CA2146260A1 (en) 1994-05-11
FI934800A (fi) 1994-05-01
CZ280669B6 (cs) 1996-03-13
IL107347A0 (en) 1994-01-25
AU669206B2 (en) 1996-05-30
DK0666854T3 (da) 1997-04-28
TW299231B (xx) 1997-03-01
CZ111095A3 (en) 1995-11-15
CA2146260C (en) 1998-04-07
HUT65472A (en) 1994-06-28
MX9306796A (es) 1994-04-29
JPH07508756A (ja) 1995-09-28
ZA938091B (en) 1995-05-02

Similar Documents

Publication Publication Date Title
EG20280A (en) Process for preparing of fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
DK0792268T3 (da) Hypolipidæmiske benzothiazepiner
DE69633607D1 (de) Piperidinderivate mit tachykinin-antagonistischer wirkung
ATE149497T1 (de) Azanorbornanderivate
RU94022743A (ru) Амидо- или карбамидо-производные, обладающие антигиперхолестериновой активностью, и фармацевтическая композиция на их основе
DK0666854T3 (da) Neurobeskyttende 3,4-dihydro-2(1H)-quinolon forbindelser
DK26289D0 (da) Anvendelse af 1,4-disubstitueret piperidinyl til fremstilling af et farmaceutisk praeparat til behandling af insomnia
ATE161725T1 (de) Verwendung von phosphatdiestern zur behandlung von erkrankungen der retina
HUT50325A (en) Process for producing bisphenylalkyl piperazine derivatives and pharmaceutical compositions comprising same as active ingredient
GR3034226T3 (en) 4-p-fluorobenzoyl-1-piperidinyl-propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis and schizophrenia
DE69400702D1 (de) N-acylpyrrolidine und arzneimittel zur behandlung oder prophylaxe von mit ckk und gastrin in zusammenhang stehenden krankheiten